Cargando…
Herpes zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in New Zealand: a retrospective cohort study
BACKGROUND: Herpes zoster (HZ) and associated complications cause significant burden to older people. A HZ vaccination programme was introduced in Aotearoa New Zealand in April 2018 with a single dose vaccine for those aged 65 years and a four-year catch up for 66–80 year-olds. This study aimed to a...
Autores principales: | Mbinta, James F., Wang, Alex X., Nguyen, Binh P., Paynter, Janine, Awuni, Prosper Mandela A., Pine, Russell, Sporle, Andrew A., Simpson, Colin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985042/ https://www.ncbi.nlm.nih.gov/pubmed/36879782 http://dx.doi.org/10.1016/j.lanwpc.2022.100601 |
Ejemplares similares
-
Herpes zoster vaccine safety in the Aotearoa New Zealand population: a self-controlled case series study
por: Mbinta, James F., et al.
Publicado: (2023) -
Postlicensure herpes zoster vaccine effectiveness: systematic review protocol
por: Mbinta, James F, et al.
Publicado: (2021) -
Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment
por: Jeon, Young Hoon
Publicado: (2015) -
Osteopathic Manipulative Treatment of Herpes Zoster Ophthalmicus/Postherpetic Neuralgia
por: Volokitin, Mikhail, et al.
Publicado: (2021) -
914. Incidence of Herpes Zoster and Postherpetic Neuralgia and Herpes Zoster Vaccination in a United States Administrative Claims Database
por: Jain, Purva, et al.
Publicado: (2023)